Skip to main content
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Anti-Inflammatory & Anti-Allergy Agents.

Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Anti-Inflammatory & Anti-Allergy Medicinal Chemistry.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Anti-Inflammatory & Anti-Allergy Agents drug discovery.

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents) was previously published as Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents.

Publisher: Bentham Science Publishers

More about this publication?
Volume 5, Number 2, 2006

Articles

Favourites:
ADD

Immediate and Late Adverse Reactions to Iodinated Contrast Media: A Pharmacological Point of View
pp. 105-117(13)
Authors: Dewachter, Pascale; Laroche, Dominique; Mouton-Faivre, Claudie; Clement, Olivier

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Group II Secretory PLA2: A New Cardiovascular Risk Factor
pp. 163-173(11)
Authors: Krijnen, Paul A.J.; Nijmeijer, Remco; Hack, C. E.; Niessen, Hans W.M.

Favourites:
ADD

3D QSAR Study of Human PLA2 Inhibitors. A Modeling Approach to Select New and Specific Anti-Inflammatory Drugs
pp. 175-187(13)
Authors: Pintore, Marco; Mombelli, Enrico; Wechman, Christophe; Chretien, Jacques R.

Favourites:
ADD

Synthetic Inhibitors of Group IVA and Group VIA Phospholipase A2
pp. 189-203(15)
Authors: Magrioti, Victoria; Kokotos, George

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content